Institutional Ownership
Monopar Therapeutics Inc
CUSIP 61023L207COM NEWMNPRQ1 2026
13D / 13G Filings
18
Schedule 13D/13G on record
Beneficial Filers
10
Distinct reporting persons
Largest Stake
19.5%
Max % of class reported
Institutional Holders
77
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
18 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Ra Capital Management, L.P. | 13G/A | 9.9% | 667.6K | SEC |
| 2 | Feb 6, 2026 | Astrazeneca PLC | 13G/A | 7.8% | 522.7K | SEC |
| 3 | Jan 30, 2026 | Tactic Pharma LLC | 13D/A | 4.5% | — | SEC |
| 4 | Nov 14, 2025 | Janus Henderson Group PLC | 13G/A | 19.5% | 1.29M | SEC |
| 5 | Nov 14, 2025 | Ra Capital Management, L.P. | 13G/A | 9.9% | 742.9K | SEC |
| 6 | Sep 24, 2025 | Tactic Pharma LLC | 13D/A | 7.5% | — | SEC |
| 7 | Aug 14, 2025 | Janus Henderson Group PLC | 13G/A | 19.2% | 1.17M | SEC |
| 8 | May 14, 2025 | Janus Henderson Group PLC | 13G/A | 18.6% | 1.13M | SEC |
| 9 | Feb 14, 2025 | Ra Capital Management, L.P. | 13G/A | 9.9% | 620.1K | SEC |
| 10 | Feb 14, 2025 | Tang Capital Management, LLC | 13G/A | — | — | SEC |
8 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Monopar Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Janus Henderson Group PLC | 1.32M | $72.06M |
| 2 | Ra Capital Management, L.P. | 667.2K | $36.56M |
| 3 | Saturn V Capital Management LP | 345.6K | $18.94M |
| 4 | Deerfield Management Company, L.P. | 323.7K | $17.74M |
| 5 | Blackrock, Inc. | 316.6K | $17.34M |
| 6 | Adage Capital Partners Gp, L.L.C. | 309.2K | $16.94M |
| 7 | Siren, L.L.C. | 270.1K | $14.80M |
| 8 | Adar1 Capital Management, LLC | 264.3K | $14.48M |
| 9 | Polar Capital Holdings PLC | 226.5K | $12.41M |
| 10 | Wellington Management Group LLP | 174.3K | $9.55M |